Carcinogenesis Advance Access published online on August 21, 2006
Carcinogenesis, doi:10.1093/carcin/bgl149
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030
* To whom correspondence should be addressed. STK15/Aurora A is a centrosome-localized serine/threonine kinase that functions primarily in centrosome maturation and mitotic spindle assembly. In a large lung cancer case-control study of 1401 cases and 1397 controls including three ethnic groups, we examined the associations between two non-synonymous SNPs (Phe31Ile and Val57Ile) of the STK15 gene and lung cancer risk. There were statistically significant differences in the distribution of the genotypes (P < 0.0001) and haplotypes (P < 0.0001) by ethnicity for the Phe31Ile, but not the Val57Ile variant. Caucasians with the homozygous variant Phe31Ile genotype (Ile/Ile) were at a significantly reduced risk for lung cancer (OR=0.63, 95% CI = 0.41-0.96). The variant allele of Val57Ile was not associated with lung cancer risk overall. However, men with the homozygous variant genotype (Ile/Ile) had a reduced lung cancer risk as compared with men with the wild type genotype (Val/Val) (OR = 0.42, 95% CI = 0.19-0.94). When we performed joint analysis of these two polymorphisms, compared to the reference group (TT + GG, 40.99% of controls), homozygous Ile31 allele/wild type Val57 allele (AA + GG) carriers (5.45% of controls) exhibited a reduced lung cancer risk (OR = 0.78, 95% CI = 0.63 - 0.97). This is the first epidemiological study to report significant associations between STK15 polymorphisms and lung cancer risk.
Received March 20, 2006
Revised July 28, 2006
Accepted August 4, 2006
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION
Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians
Jian Gu 1, Yubo Gong 1, Maosheng Huang 1, Charles Lu 2, Margaret R. Spitz 1, and Xifeng Wu 1 *
2 Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030
Xifeng Wu, E-mail: xwu{at}mdanderson.org
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
O. Gautschi, J. Heighway, P. C. Mack, P. R. Purnell, P. N. Lara Jr., and D. R. Gandara Aurora Kinases as Anticancer Drug Targets Clin. Cancer Res., March 15, 2008; 14(6): 1639 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, D. Li, C. Wei, S. Sen, A. M. Killary, C. I. Amos, D. B. Evans, J. L. Abbruzzese, and M. L. Frazier Aurora-A and p16 Polymorphisms Contribute to an Earlier Age at Diagnosis of Pancreatic Cancer in Caucasians Clin. Cancer Res., May 15, 2007; 13(10): 3100 - 3104. [Abstract] [Full Text] [PDF] |
||||
